Found: 66
Select item for more details and to access through your institution.
Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper.
- Published in:
- Pediatric Allergy & Immunology, 2023, v. 34, n. 1, p. 1, doi. 10.1111/pai.13900
- By:
- Publication type:
- Article
Persistent ventilation inhomogeneity after an acute exacerbation in preschool children with recurrent wheezing.
- Published in:
- Pediatric Allergy & Immunology, 2020, v. 31, n. 6, p. 608, doi. 10.1111/pai.13245
- By:
- Publication type:
- Article
Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects.
- Published in:
- Pediatric Allergy & Immunology, 2014, v. 25, n. 8, p. 788, doi. 10.1111/pai.12310
- By:
- Publication type:
- Article
Food protein-induced enterocolitis syndrome in a tertiary pediatric center: safety of guideline-conforming food challenges.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2022, v. 18, n. 1, p. 1, doi. 10.1186/s13223-022-00694-y
- By:
- Publication type:
- Article
Evidence for a Role of TGF-β-Activated Kinase 1 and MAP3K7 Binding Protein 3 in Peanut-Specific T-Cell Responses.
- Published in:
- International Archives of Allergy & Immunology, 2019, v. 179, n. 1, p. 10, doi. 10.1159/000496438
- By:
- Publication type:
- Article
How Low Should We Go?
- Published in:
- International Archives of Allergy & Immunology, 2016, v. 168, n. 3, p. 147, doi. 10.1159/000443764
- By:
- Publication type:
- Article
Component-Resolved IgE Profiles in Austrian Patients with a Convincing History of Peanut Allergy.
- Published in:
- International Archives of Allergy & Immunology, 2015, v. 166, n. 1, p. 13, doi. 10.1159/000371422
- By:
- Publication type:
- Article
Test for respiratory and asthma control in preschool kids in the emergency department as a predictor of wheezing exacerbations.
- Published in:
- Pediatric Pulmonology, 2020, v. 55, n. 2, p. 338, doi. 10.1002/ppul.24601
- By:
- Publication type:
- Article
Diagnosis of Ibuprofen allergy through oral challenge.
- Published in:
- Clinical & Experimental Allergy, 2020, v. 50, n. 5, p. 636, doi. 10.1111/cea.13596
- By:
- Publication type:
- Article
Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Impact of systemic immuno-suppression after solid organ transplantation on allergen-specific responses.
- Published in:
- Allergy, 2011, v. 66, n. 2, p. 271, doi. 10.1111/j.1398-9995.2010.02475.x
- By:
- Publication type:
- Article
IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 6, p. 1535, doi. 10.1002/eji.201141668
- By:
- Publication type:
- Article
Improving "may contain" labels: A call to team up and share data.
- Published in:
- Allergy, 2024, v. 79, n. 6, p. 1409, doi. 10.1111/all.16012
- By:
- Publication type:
- Article
EAACI guidelines on the diagnosis of IgE‐mediated food allergy.
- Published in:
- Allergy, 2023, v. 78, n. 12, p. 3057, doi. 10.1111/all.15902
- By:
- Publication type:
- Article
An update on recent developments and highlights in food allergy.
- Published in:
- Allergy, 2023, v. 78, n. 9, p. 2344, doi. 10.1111/all.15749
- By:
- Publication type:
- Article
The artificial intelligence (AI) revolution: How important for scientific work and its reliable sharing.
- Published in:
- Allergy, 2023, v. 78, n. 8, p. 2085, doi. 10.1111/all.15778
- By:
- Publication type:
- Article
An alternative path to oral tolerance.
- Published in:
- Allergy, 2023, v. 78, n. 7, p. 2058, doi. 10.1111/all.15701
- By:
- Publication type:
- Article
Introducing peanut early in life – Ready for the general population?
- Published in:
- Allergy, 2023, v. 78, n. 5, p. 1142, doi. 10.1111/all.15676
- By:
- Publication type:
- Article
Oral immunotherapy for food allergy: What's age got to do with it?
- Published in:
- Allergy, 2023, v. 78, n. 3, p. 626, doi. 10.1111/all.15623
- By:
- Publication type:
- Article
Precision cut intestinal slices, a novel model of acute food allergic reactions.
- Published in:
- Allergy, 2023, v. 78, n. 2, p. 500, doi. 10.1111/all.15579
- By:
- Publication type:
- Article
The impact of maternal‐fetal omalizumab transfer on peanut‐specific responses in an ex vivo placental perfusion model.
- Published in:
- Allergy, 2022, v. 77, n. 12, p. 3684, doi. 10.1111/all.15468
- By:
- Publication type:
- Article
Platelet‐activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children.
- Published in:
- Allergy, 2022, v. 77, n. 9, p. 2665, doi. 10.1111/all.15308
- By:
- Publication type:
- Article
COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2313, doi. 10.1111/all.15252
- By:
- Publication type:
- Article
Management of allergic diseases in pregnancy.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 798, doi. 10.1111/all.15063
- By:
- Publication type:
- Article
EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old.
- Published in:
- Allergy, 2022, v. 77, n. 1, p. 17, doi. 10.1111/all.15030
- By:
- Publication type:
- Article
When and how to evaluate for immediate type food allergy in children with atopic dermatitis.
- Published in:
- Allergy, 2021, v. 76, n. 12, p. 3845, doi. 10.1111/all.14982
- By:
- Publication type:
- Article
Biological treatment in allergic disease.
- Published in:
- Allergy, 2021, v. 76, n. 9, p. 2934, doi. 10.1111/all.14954
- By:
- Publication type:
- Article
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines.
- Published in:
- Allergy, 2021, v. 76, n. 8, p. 2337, doi. 10.1111/all.14809
- By:
- Publication type:
- Article
Emollients for the prevention of atopic dermatitis.
- Published in:
- Allergy, 2021, v. 76, n. 8, p. 2641, doi. 10.1111/all.14650
- By:
- Publication type:
- Article
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1640, doi. 10.1111/all.14840
- By:
- Publication type:
- Article
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1629, doi. 10.1111/all.14739
- By:
- Publication type:
- Article
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis.
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 988, doi. 10.1111/all.14690
- By:
- Publication type:
- Article
Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy".
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 1300, doi. 10.1111/all.14636
- By:
- Publication type:
- Article
Infant feeding clusters are associated with respiratory health and allergy at school age in the PARIS birth cohort.
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 1223, doi. 10.1111/all.14568
- By:
- Publication type:
- Article
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study.
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 1235, doi. 10.1111/all.14200
- By:
- Publication type:
- Article
Modeling the conversion between specific IgE test platforms for nut allergens in children and adolescents.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 831, doi. 10.1111/all.14529
- By:
- Publication type:
- Article
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020).
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 689, doi. 10.1111/all.14471
- By:
- Publication type:
- Article
COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 648, doi. 10.1111/all.14453
- By:
- Publication type:
- Article
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines.
- Published in:
- Allergy, 2021, v. 76, n. 1, p. 59, doi. 10.1111/all.14547
- By:
- Publication type:
- Article
Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines.
- Published in:
- Allergy, 2021, v. 76, n. 1, p. 45, doi. 10.1111/all.14510
- By:
- Publication type:
- Article
EAACI Biologicals Guidelines—Recommendations for severe asthma.
- Published in:
- Allergy, 2021, v. 76, n. 1, p. 14, doi. 10.1111/all.14425
- By:
- Publication type:
- Article
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.
- Published in:
- Allergy, 2020, v. 75, n. 12, p. 3039, doi. 10.1111/all.14582
- By:
- Publication type:
- Article
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI).
- Published in:
- Allergy, 2020, v. 75, n. 10, p. 2445, doi. 10.1111/all.14462
- By:
- Publication type:
- Article
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2.
- Published in:
- Allergy, 2020, v. 75, n. 10, p. 2503, doi. 10.1111/all.14449
- By:
- Publication type:
- Article
Phenotype consensus is required to enable large‐scale genetic consortium studies of food allergy.
- Published in:
- Allergy, 2020, v. 75, n. 9, p. 2383, doi. 10.1111/all.14333
- By:
- Publication type:
- Article
Transfer and loss of allergen‐specific responses via stem cell transplantation: A prospective observational study.
- Published in:
- Allergy, 2020, v. 75, n. 9, p. 2243, doi. 10.1111/all.14278
- By:
- Publication type:
- Article
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma.
- Published in:
- Allergy, 2020, v. 75, n. 5, p. 1058, doi. 10.1111/all.14268
- By:
- Publication type:
- Article
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma.
- Published in:
- Allergy, 2020, v. 75, n. 5, p. 1043, doi. 10.1111/all.14235
- By:
- Publication type:
- Article
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
- Published in:
- Allergy, 2020, v. 75, n. 5, p. 1023, doi. 10.1111/all.14221
- By:
- Publication type:
- Article
Biologicals in allergic diseases and asthma: Toward personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019.
- Published in:
- Allergy, 2020, v. 75, n. 4, p. 936, doi. 10.1111/all.14024
- By:
- Publication type:
- Article